Search

Search Constraints

You searched for: Author/Creator Dumbrava, Ecaterina

Search Results

1. 285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors. (10th December 2020)

2. 285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors. (9th November 2020)

3. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. Issue 2 (23rd October 2020)

4. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. Issue 2 (23rd October 2020)

5. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. Issue 2 (23rd October 2020)

6. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. Issue 2 (23rd October 2020)

7. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. Issue 2 (23rd October 2020)

8. MLTI-10. ESTABLISHMENT OF A MULTIDISCIPLINARY BRAIN METASTASIS CLINIC TO FACILITATE PATIENT-CENTERED CARE AND COORDINATED RESEARCH. (12th August 2019)